Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.12 USD | -0.22% |
|
+0.37% | +28.58% |
20/06 | Berenberg Lifts Price Target on Lonza Group, Maintains Buy Recommendation | MT |
14/05 | Swiss Market Index Edges Up Ahead of Inflation Report | MT |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company returns high margins, thereby supporting business profitability.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 39.51 and 31.52 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Sector: Biotechnology & Medical Research
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+28.58% | 3.91TCr | - | ||
+23.13% | 4.69TCr | B- | ||
-8.73% | 3.85TCr | B | ||
+28.09% | 3.1TCr | B | ||
-12.26% | 2.61TCr | C | ||
+10.57% | 2.59TCr | B- | ||
+45.05% | 1.42TCr | B+ | ||
+32.23% | 1.25TCr | C+ | ||
-6.56% | 1.14TCr | B+ | ||
-12.56% | 1.06TCr | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LONN Stock
- LZAGY Stock
- Ratings Lonza Group AG